Comparison of the clinical outcomes of patients with NSAID-exacerbated respiratory disease receiving aspirin or biologicals.

Gülseren TuncayEbru DamadogluMelek CihanbeylerdenOzge Can BostanHazal KayıkcıSerdar ÖzerGül KarakayaAli Fuat Kalyoncu

Published in: The Journal of asthma : official journal of the Association for the Care of Asthma (2023)

In NERD patients, mepolizumab significantly decreased blood eosinophil counts and recurrent FESS. There was no significant difference between the patients receiving ATAD or mepolizumab regarding other clinical parameters.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
low dose
chronic kidney disease
prognostic factors
peritoneal dialysis
type diabetes
cardiovascular events
percutaneous coronary intervention
acute coronary syndrome
cardiovascular disease
antiplatelet therapy